In vitro determination of carcinogenicity of sixty-four compounds using a bovine papillomavirus DNA-carrying C3H/10T 1/2 cell line

Environmental and Molecular Mutagenesis

Volumn 35, Issue 4, 2000, Pages 300-311

  Kowalski, Linda A ^a   Laitinen, A M ^a   Mortazavi Asl, B ^a   Wee, R K H ^a   Erb, H E ^a   Assi, K P ^a   Madden, Z ^a  

^a Vera Genics Ltd   (Canada)

Author keywords

Carcinogenesis; Carcinogenicity testing; Mutagenesis; Papillomavirus

Indexed keywords

ACETAMIDE DERIVATIVE; ACRIDINE DERIVATIVE; AFLATOXIN; AMIDE; ANTIMETABOLITE; AROMATIC AMINE; AZO COMPOUND; CARBAMIC ACID DERIVATIVE; CISPLATIN; DIELDRIN; DIETHYLSTILBESTROL; HALIDE; HYDRAZINE DERIVATIVE; METAL; MYCOTOXIN; NITROSAMINE; PHORBOL ESTER DERIVATIVE; PHTHALIC ACID DIBUTYL ESTER; POLYCYCLIC AROMATIC HYDROCARBON; RESERPINE; SOLVENT; UREA DERIVATIVE; URETHAN;

AMES TEST; ANIMAL CELL; ARTICLE; CARCINOGEN TESTING; CARCINOGENICITY; CONTROLLED STUDY; DATA BASE; FIBROBLAST CULTURE; GENOTOXICITY; IN VITRO STUDY; INTERMETHOD COMPARISON; MUTAGENICITY; NONHUMAN; PAPILLOMA VIRUS; REPRODUCIBILITY; RODENT; XENOBIOTIC METABOLISM;

ANIMALS; BOVINE PAPILLOMAVIRUS 1; CARCINOGENICITY TESTS; CARCINOGENS; CATTLE; CELL LINE; COCULTURE TECHNIQUES; CRICETINAE; DNA, VIRAL; MICE; MICE, INBRED C3H; REPRODUCIBILITY OF RESULTS;

ANIMALIA; BACTERIA (MICROORGANISMS); BOVINAE; BOVINE PAPILLOMAVIRUS; BOVINE PAPILLOMAVIRUS TYPE 1; CRICETINAE; MESOCRICETUS AURATUS; PAPILLOMAVIRUS; RODENTIA;

EID: 0033917107     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2280(2000)35:4<300::AID-EM4>3.0.CO;2-Z     Document Type: Article

References (50)

1. Allshire RC, Bostock CJ. 1986. Structure of bovine papillomavirus type 1 DNA in a transformed mouse cell line. J. Mol. Biol 188:1-13.
2. Ames BN, McCann J, Yamasaki E. 1975. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mutation Res 31:347-364.
3. Arlauskas A, Baker RSU, Bonin AM, Tandon RK, Crisp PT, Ellis J. 1985. Mutagenicity of metal ions in bacteria. Env. Res 36:379-387.
4. Ashby J. 1980. The significance and interpretation of in vitro carcinogenicity assay results. In: Norpoth KN, Garner RC, editors. Short-term test systems for detecting carcinogens. New York: Springer-Verlag. p 74-93.
5. Auletta A. 1994. Overview of in vitro tests for genotoxic agents. In: Milman HA, Weisburger EK, editors. Handbook of carcinogen testing, second edition. New Jersey: Noyes Publishing Co. p 58-82.
6. Bertram JS. 1985. Neoplastic transformation in cell cultures: In vitro/in vivo correlations. In: Kakunaga T, Yamasaki H, editors. Transformation assay of established cell lines: Mechanisms and application. IARC Scientific Publication #67. Lyon, France: IARC. p 74-92.
7. Cantelli-Forti G, Biagli GL, Boreo PA, Bronzetti G, Guerra MC, Hrelia P, Paolioni M, Simi S, Grilli S. 1988. Relationship between structure and mutagenic/carcinogenic activity of short chain aliphatic halo-compounds. A collaborative study. In: Feo F, Pani P, Columbano A, Garcia A, editors. Chemical carcinogenesis. New York: Plenum Press, p 46-53.
8. Casto BC, Meyer J, DiPaolo JA. 1979. Enhancement of viral transformation for evaluation of the carcinogenic or mutagenic polential of inorganic metal salts. Cancer Res 39:193-198.
9. Cerutti PA. 1985. Prooxidant states and tumour promotion. Science 227: 375-381.
10. Dillon D, Edwards I, Combes R, McConville M, Zeiger E. 1992. The role of glutathione in the bacterial mutagenicity of vapour phase dichloromethane. Environ Mol Mutagen 20:211-217.
11. Dunkel VC, Zeiger E, Brusick D, McCoy E, McGregor D, Mortelmans K, Rosenkranz HS, Simmon VF. 1984. Reproducibility of microbial mutagenicity assays: I: Tests with Salmonella typhimurium and Escherichia coli using a standardized protocol. Environ Mutagen 6(suppl 2):1-251.
12. Garner RC. 1980. In vitro assays to predict carcinogenicity. In: Norpoth KN, Garner RC, editors. Short-term test systems for detecting carcinogens. New York: Springer-Verlag. p 5-18.
13. Garrett LR, Perez-Reyes N, Smith PP, McDougall JK. 1993. Interaction of HPV-18 and nitrosomethylurea in the induction of squamous cell carcinoma. Carcinogenesis 14:329-332.
14. Glatt HR, Schwind H, Schechtman LM, Beard S, Kouri RE, Zajdela F, Croisy A, Perin F, Jacquignon PC, Oesch F. 1980. Mutagenicity of closely related carcinogenic and noncarcinogenic compounds using various metabolizing systems and target cells. In: Norpoth KN, Garner RC, editors. Short-term test systems for detecting carcinogens. New York: Springer-Verlag. p 103-126.
15. Haworth S, Lawlor T, Mortelmans K, Speck W, Zeiger E. 1983. Salmonella mutagenicity test results: I. Results from the testing of 250 chemicals. Environ Mutagen 5(suppl 1):3-49.
16. Heidelberger , Freeman AE, Pienta RJ, Sivak A, Bertram JS, Casio BC, Dunkel VC, Francis MW, Kakunaga T, Little JB, Schechtman LM. 1983. Cell transformation by chemical agents-a review and analysis of the literature. A report of the U.S. Environmental Protection Agency Gene-Tox program. Mutat Res 114:283-385.
17. International Agency for Research on Cancer. 1983. Monographs on the evaluation of carcinogenic risk of chemicals to man. Lyon, France: IARC. 32(suppl 7):83.
18. International Agency for Research on Cancer. 1987a. Monographs on the evaluation of carcinogenic risk of chemicals to man. Lyon, France: IARC. 7(suppl 7):73.
19. International Agency for Research on Cancer. 1987b. Monographs on the evaluation of carcinogenic risk of chemicals to man. Lyon, France: IARC. 12(suppl 7):116.
20. International Agency for Research on Cancer. 1987c. Monographs on the evaluation of carcinogenic risk of chemicals to man. Lyon, France: IARC. 32(suppl 7):83.
21. International Agency for Research on Cancer. 1987d. Monographs on the evaluation of carcinogenic risk of chemicals to man. Lyon, France: IARC. suppl 7:210.
22. International Agency for Research on Cancer. 1990. Monographs on the evaluation of carcinogenic risk of chemicals to man. Lyon, France: IARC. 49:49.
23. Isfort RJ, Kerckaert GA, LeBoeuf RA. 1996. Comparison of the standard and reduced pH Syrian hamster embryo (SHE) cell in vitro transformation assays in predicting the carcinogenic potential of chemicals. Mutat Res 356:11-63.
24. Jarrett WFH, McNeil PE, Grimshaw TR, Selman IE, McIntyre WIM. 1978. High incidence area of cattle cancer with a possible interaction between an environmental carcinogen and a papillomavirus. Nature 274:215-217.
25. Kerckaert GA, LeBoeuf RA, Isfort RJ. 1998. Assessing the predictiveness of the Syrian hamster embryo cell transformation assay for determining the rodent carcinogenic potential of single ring aromatic/ nitroaromatic amine compounds. Toxicol Sci 41:189-197.
26. Kerckaert GA, Isfort RJ, Carr GJ, Aardema MJ, LeBoeuf RA, 1996. A comprehensive protocol for conducting the Syrian hamster embryo cell transformation assay at pH 6.70. Mutat Res 356:65-84.
27. Kowalski LA, Tsang S-S, Davison AJ. 1992. Vanadate enhances transformation of bovine papillomavirus DNA-transfected C3H/10T1/2 cells. Cancer Lett 64:83-90.
28. Kowalski LA. 1995. Enhancement of bovine papillomavirus DNA-mediated transformation of C3H/10T1/2 cells by carcinogenic metals and suppression of transformation by ascorbate and retinol. Ph.D. thesis, Simon Fraser University, Burnaby, B.C. Canada.
29. Kowalski LA, Wei J-Z, Laitinin AM. 1996. Enhancement of transformation of BPV E5-transfected C3H/10T1/2 cells by carcinogens. Abstract, 15th International Papillomavirus Conference: Gold Coast, Australia.
30. th International Papillomavirus Conference: Charleston, SC.
31. Landolph JR. 1985. Chemical transformation in C3H/10T1/2 C8 mouse embryo fibroblasts: historical background, assessment of the transformation assay, and evolution and optimization of the transformation assay protocol. In: Kakunaga T, Yamasaki H. editors. Transformation assay of established cell lines: Mechanisms and application. IARC Scientific Publication #67. Lyon, France: IARC. p 185-219.
32. Law M-F, Lowy DR, Dvoretzky I, Howley PM. 1981. Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences. Proc Natl Acad Sci U S A 78:2727-2731.
33. LeBoeuf RA, Kerckaert GA, Aardema MJ, Gibson DP, Brauniger R, Isfort RJ. 1996. The pH 6.7 Syrian hamster embryo cell transformation assay for assessing the carcinogenic potential of chemicals. Mutat Res 356:85-127.
34. Lee TC, Oshimura M, Barrett JC. 1985. Comparison of arsenic-induced cell transformation, cytotoxicity, mutation and cytogenetic effects in Syrian hamster embryo cells in culture. Carcinogenesis 6:1421-1426.
35. McCann J, Choi E, Yamasaki E, Ames BN. 1975. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc Natl Acad Sci U S A 72:5135-5139.
36. Mortelmans K, Haworth S, Lawlor T, Speck W, Tainer B, Zeiger E. 1986. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. Environ Mutagen 8(suppl 7):1-119.
37. National Testing Program (U.S.). 1987. Technical report number 328.
38. Parkinson A. 1996. An overview of current cytochrome P450 technology for assessing the safety and efficacy of new materials. Toxicol Pathway 24:45-57.
39. Petti L, Nilson LA, DiMaio D. 1991. Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming region. EMBO J 10:845-855.
40. Rossman TG, Stone D, Molina M, Troll W. 1980. Absence of arsenite mutagenicity in E. coli and CHO cells. Environ Mutagen 2:371-379.
41. Sarver N, Rabson MS, Byrne JC, Howley PM. 1982. Transformation and replication in mouse cells of a bovine papillomavirus pML2d plasmid vector that can be rescued in bacteria. Proc Natl Acad Sci U S A 79:7147-7151.
42. Sarver N, Rabson MS, Yang Y-C, Byrne JC, Howley PM. 1984. Localization and analysis of bovine papillomavirus type-1 transforming functions. J Virol 52:377-388.
43. 5. Environ Sci Res 31:834-835.
44. Stocks P. 1960. On the relationship between atmospheric pollution in urban and rural localities and mortality from cancer, bronchitis, pneumonia with particular reference to 3,4-benzopyrene, beryllium, molybdenum, vanadium and arsenic. Br J Cancer 14:397-418.
45. Tsang S-S, Stich HF,. 1988. Enhancement of bovine papillomavirus-induced cell transformation by tumour promoters. Cancer Lett 43:93-98.
46. U.S. Department of Health and Human Services. Public Health Service. National Toxicology Program 1998 Report on Carcinogens.
47. Zeiger E, Haworth S. 1985. Tests with a preincubation modification of the Salmonella/microsome assay. In: Ashby J, de Serres FJ, Draper M, Ishidate M Jr, Margolin BH, Matter B, Shelby MD. editors. Evaluation of short-term tests for carcinogens. North Holland: Elsevier. p 187-199.
48. Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K, Speck W. 1987. Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. Environ Mutagen 9(suppl 9):1-110.
49. Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K. 1988. Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals. Environ Mol Mutagen 2(suppl 12):1-158.
50. Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K. 1992. Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals. Environ Mol Mutagen 19(suppl 21):2-141.